AVDL

Avadel Pharmaceuticals plc

Last Updated:

Q3 '20

Price

quotes and stock data delayed 15 minutes

Cash

$233.1M

Burn Rate (Qtr)

$11.7M

Company Profile

We are a biopharmaceutical company passionately committed to providing solutions for overlooked and unmet medical needs through patient-focused, innovative products.

Drug Pipeline

Click on drug name or indication to see upcoming trial info, prior data, and more general information

Drug | Disease (links)

Stage (next event)

Catalyst Date

FT218

Excessive Daytime Sleepiness and Cataplexy in Patients with Narcolepsy

NDA Filing

December 2020

Recent Posts

See what the community is saying - click to see full post

*Disclaimer: Information provided on ampbiotechresearch.com and in any of our reports, products and services are for information only and are not investment advice. Please consult with an investment adviser and do your own diligence before making any investment decisions or taking any action.  By accessing this site, you agree to our Terms of Use and Privacy Policy that can be accessed here. Amp Core™ is a trademark of Amp Biotech Research, LLC

©2020 BY Amp Biotech Research

  • Twitter Social Icon
  • LinkedIn Social Icon